Henry T Lynch

发表

Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers.

Daniel Krewski, Susan L Neuhausen, Jan Lubinski, 2010, Breast.

Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations

Karthik Devarajan, Yan Zhou, Andrew K Godwin, 2010, Cancer Prevention Research.

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

Nandita Mitra, Georgia Chenevix-Trench, Susan L Neuhausen, 2009, Cancer research.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Giovanni Parmigiani, Susan G Hilsenbeck, Judy E Garber, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking.

David D Jones, Hemant K Roy, R. Brand, 2006, World journal of gastroenterology.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Ellen Warner, Ping Sun, Olufunmilayo I Olopade, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hereditary pancreatic cancer: a clinical perspective.

R. Brand, H. Lynch, J. Greer, 2009, Best practice & research. Clinical gastroenterology.

The risk of breast cancer in women with a BRCA1 mutation from North America and Poland

Susan L Neuhausen, Jan Lubinski, Kevin Sweet, 2012, International journal of cancer.

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.

Hemant K Roy, T. Smyrk, H. Lynch, 2002, Carcinogenesis.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2002, The New England journal of medicine.

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Sudhir Srivastava, Scott D Ramsey, Andrew N Freedman, 2004, Journal of the National Cancer Institute.

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers

Daniel L Gillen, Susan L Neuhausen, Fergus Couch, 2009, Breast Cancer Research.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Rodney J Scott, Finlay Macrae, Annika Lindblom, 2011, The Lancet.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Rosalind Eeles, Susan L Neuhausen, Fergus J Couch, 2010, JAMA.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.